Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
stromal vascular fraction (Esbjerg Hospital - University Hospital of Southern Denmark)
- Development stage
- Unknown
- Lead developer
- Hospital of South West Jutland
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intralesional
01
Overview
Stromal vascular fraction (SVF), also known as adipose-derived regenerative cells (ADRCs), is an investigational autologous cell therapy being developed by Esbjerg Hospital - University Hospital of Southern Denmark for the treatment of chronic Peyronie's disease. SVF is a complex mixture of cells obtained from a patient's own adipose tissue via liposuction, containing adipose-derived stem cells (ADSCs), mesenchymal stem cells (MSCs), endothelial precursor cells, and various immune modulatory cells. The therapy involves a same-day procedure where the harvested fat is processed to isolate the SVF, which is then injected directly into the Peyronie's disease plaque (fibrosis) in the tunica albuginea. The mechanism of action relies on the regenerative, anti-inflammatory, and angiogenic properties of the stem and progenitor cells, which aim to remodel the fibrous tissue and reduce penile curvature. This approach is currently being evaluated in a Phase 1 prospective pilot study (NCT04771442).
- Other names
- adipose-derived regenerative cellsADRCsautologous stromal vascular fraction
Beyond the preview
Go deeper on stromal vascular fraction (Esbjerg Hospital - University Hospital of Southern Denmark).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on stromal vascular fraction (Esbjerg Hospital - University Hospital of Southern Denmark).